A detailed history of Banque Pictet & Cie Sa transactions in Novo Nordisk A S stock. As of the latest transaction made, Banque Pictet & Cie Sa holds 21,742 shares of NVO stock, worth $1.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
21,742
Previous 7,177 202.94%
Holding current value
$1.9 Million
Previous $1.02 Million 152.73%
% of portfolio
0.02%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$119.07 - $145.42 $1.73 Million - $2.12 Million
14,565 Added 202.94%
21,742 $2.59 Million
Q2 2024

Jul 25, 2024

BUY
$122.71 - $146.91 $880,689 - $1.05 Million
7,177 New
7,177 $1.02 Million
Q3 2023

Nov 02, 2023

BUY
$90.94 - $199.54 $115,130 - $252,617
1,266 Added 100.0%
2,532 $230,000
Q1 2023

May 01, 2023

SELL
$132.34 - $159.14 $191,893 - $230,752
-1,450 Reduced 53.39%
1,266 $201,000
Q4 2022

Feb 06, 2023

BUY
$102.55 - $135.33 $278,525 - $367,556
2,716 New
2,716 $0

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Banque Pictet & Cie Sa Portfolio

Follow Banque Pictet & Cie Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Pictet & Cie Sa, based on Form 13F filings with the SEC.

News

Stay updated on Banque Pictet & Cie Sa with notifications on news.